These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 18369701)
1. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population. Azad RV; Khan MA; Chanana B; Azad S Jpn J Ophthalmol; 2008; 52(1):52-6. PubMed ID: 18369701 [TBL] [Abstract][Full Text] [Related]
2. Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up. Arevalo JF; Fromow-Guerra J; Sanchez JG; Maia M; Berrocal MH; Wu L; Saravia MJ; Costa RA; Retina; 2008; 28(10):1387-94. PubMed ID: 18827735 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration. Bashshur ZF; Bazarbachi A; Schakal A; Haddad ZA; El Haibi CP; Noureddin BN Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245 [TBL] [Abstract][Full Text] [Related]
19. Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. Rothenbuehler SP; Waeber D; Brinkmann CK; Wolf S; Wolf-Schnurrbusch UE Am J Ophthalmol; 2009 May; 147(5):831-7. PubMed ID: 19217019 [TBL] [Abstract][Full Text] [Related]
20. Bevacizumab treatment for choroidal neovascularization due to age-related macular degeneration in Japanese patients. Suzuki M; Gomi F; Sawa M; Tsujikawa M; Sakaguchi H Jpn J Ophthalmol; 2010 Mar; 54(2):124-8. PubMed ID: 20401560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]